AMBUJACEMBSEAMBUJA CEMENTS LTD· Cement & Cement ProductsHighNeutral
Announced Wed, 30 Sept, 2026 · 19:29 IST

NCLT meeting approves ACC amalgamation with Ambuja Cements

Nclt Scheme FiledStrategic Transactions View source PDFExplain this filing

AMBUJACEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-3.1%Reaction day
₹374.00
prior close
₹371.50
announcement price
After-mkt
timing
Nifty 100market-0.9%-2.2% vs market
Cement & Cement Products peers, median of 35sector-2.0%-1.1% vs sector

On the reaction day the stock moved 2.2 pts less than Nifty 100 and 1.1 pts less than its Cement & Cement Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.7
10m
-1.6
15m
-1.0
30m
-1.2
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-3.1-0.9-2.2-2.0-1.1
Next day
-2.0-0.4-1.6-2.3+0.3
2d
-3.3+0.6-4.0-2.4-1.0
3d
-4.7-0.2-4.5-3.2-1.4
4d
-8.8-2.0-6.9-4.5-4.3
5d
-6.0-0.8-5.2-4.9-1.1
1w
-6.6+0.1-6.7-4.3-2.3
15d
-0.7-0.4-0.3-7.9+7.2
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty 100Sector · Cement & Cement Products peers, median of 35Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Combined Scrutinizer's Report confirms equity shareholders approved the Scheme of Amalgamation of ACC Limited with Ambuja Cements at the NCLT convened meeting on September 29, 2026. Of 2,268,120,094 valid votes cast, 99.98% voted in favour (2,267,313,887 shares) and only 0.02% against (547,772 shares). Promoters voted 100% in favour, public institutions 99.91%, and public non-institutions 99.92%.

Likely market impact

Strong shareholder approval clears the path for NCLT to sanction the ACC-Ambuja merger, subject to remaining regulatory and court approvals.